Evidence map›Paper›PMID 32426933›Full record

ReviewJournal of cosmetic dermatology2020

Nonprescription acne vulgaris treatments: Their role in our treatment armamentarium-An international panel discussion.

Brigitte Dréno, Elena Araviiskaia, Delphine Kerob, Anneke Andriessen, Maryna Anfilova, Monika Arenbergerova, Olga L Forero Barrios, Zrinka Bukvić Mokos, Merete Haedersdal, Maja A Hofmann and 9 more

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of cosmetic dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Effectiveness and Safety of a Moisturizer Containing Centella Asiatica Extract, Ceramide NP, and Panthenol for Erythema and Skin Barrier in Erythematotelangiectatic Rosacea: A Randomized Controlled Trial Study.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Skin Pigmentation Types, Causes and Treatment-A Review.Molecules (Basel, Switzerland) · 2023
    Review
  12. Review
  13. By-product of Korean liquor fermented byFood science and biotechnology · 2022
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 19 institutions in 17 countries.

Brigitte DrénoCell Therapy and Gene Therapy Unit, Department of Dermato-Oncology, The Faculty of Medicine, University of Nantes, Nantes, France.ORCID https://orcid.org/0000-0001-5574-5825
Elena AraviiskaiaDepartment of Dermatology & Venereology, First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russia.ORCID https://orcid.org/0000-0002-6378-8582
Delphine KerobInternational Medical Relations, Laboratoire Vichy, Chevilly-Larue, France.ORCID https://orcid.org/0000-0003-2816-4261
Anneke AndriessenNijmegen and Andriessen Consultants, Radboud UMC, Malden, The Netherlands.ORCID https://orcid.org/0000-0001-5930-4162
Maryna AnfilovaDepartment of Skin and Venereal Diseases, National Pirogov Memorial Medical University, Vinnytsya, Ukraine.ORCID https://orcid.org/0000-0001-5609-7399
Monika ArenbergerovaDepartment of Dermato-Venereology, Third Faculty of Medicine, Charles University and University Hospital of Kralovske Vinohrady, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-7919-9619
Olga L Forero BarriosCentro de Dermatologia, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0001-9652-2783
Zrinka Bukvić MokosDepartment of Dermatology and Venereology, School of Medicine University of Zagreb, University Hospital Center Zagreb, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-1180-9759
Merete HaedersdalBispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-1250-2035
Maja A HofmannDepartment of Dermatology, Venereology, and Allergy, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3859-234X
Ziad KhamaysiDepartment of Dermatology, Rambam Medical Center and Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.ORCID https://orcid.org/0000-0001-9586-2807
Marita KosmadakiBoston University, Boston, MA, USA.ORCID https://orcid.org/0000-0003-1723-5036
Aleksandra LesiakDermatology and Venereology Clinic, Medical University, Łodź, Poland.ORCID https://orcid.org/0000-0003-3318-729X
Elia RoóClider-Clínica Dermatológica, Madrid, Spain.ORCID https://orcid.org/0000-0002-7745-2924
Anca Zbranca-ToporasDepartment of Biomedical Sciences, Faculty of Bioengineering, University of Medicine and Pharmacy Grigore T.Popa, Iasi, Romania.ORCID https://orcid.org/0000-0002-5474-4182
Marni C WisemanDepartments of Medicine and Dermatology, University of Manitoba, Winnipeg, MB, Canada.ORCID https://orcid.org/0000-0001-9634-3750
Sameer ZimmoKing Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0002-0796-7586
Lucie GuerinL'Oréal Research and Innovation, Chevilly-Larue, France.ORCID https://orcid.org/0000-0001-6978-9933
Gabriella FabbrociniDepartment of Clinical Medicine and Surgery, Dermatology, Section of Dermatology, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0002-0064-1874
Boston University · USCentro Brasileiro de Estudos em Dermatologia · BRCharité - Universitätsmedizin Berlin · DECharles University · CZClínica Rementería · ESFirst Pavlov State Medical University of St. Petersburg · RUGene Therapy Laboratory · FRGrigore T. Popa University of Medicine and Pharmacy · ROInstitut Européen De La Qualité Totale · FRKing Abdulaziz University · SAL'Oréal (France) · FRMedical University of Lodz · PLNational Pirogov Memorial Medical University, Vinnytsya · UARadboud University Nijmegen · NLTechnion – Israel Institute of Technology · ILUniversity Hospital Centre Zagreb · HRUniversity of Copenhagen · DKUniversity of Manitoba · CAUniversity of Naples Federico II · IT

Funding

Vichy Laboratoires, France
6 · The paper itself

Abstract

backgroundAcne vulgaris (acne), a common inflammatory skin disorder, has its peak incidence between 14 and 19 years of age, with girls frequently developing acne earlier than boys. Over recent years, persistent acne is becoming more prevalent in adult women.

objectivesThis review and panel discussion addresses challenges in acne management, particularly in adult women. The role which nonprescription acne treatment can play is explored when used as monotherapy or as an adjunctive treatment for acne of all severity.

methodsThe best available evidence on nonprescription acne treatment was coupled with the opinion of an international expert panel of dermatologists to adopt statements and recommendations discussed in this review.

resultsAll severity of acne has a significant burden on patients. Addressing environmental factors that are important for the individual with acne may help to educate, prevent, effectively manage, and maintain acne, as per the panel. They agreed that the adult female acne population has unique needs because of their aging skin and social environment. Nonprescription acne treatment products may help to balance the efficacy and tolerability of prescription acne treatment. Currently, there are no specific guidelines for how to use nonprescription acne treatment products in these patients.

conclusionThe panel agreed that guidelines including nonprescription acne treatment either as monotherapy for mild acne or in combination with prescription treatments for more severe acne would address a significant unmet need.

Indexed as

Acne VulgarisDermatologic AgentsSkin AgingAdultFemaleHumansMaleSkinDermatologic Agentsacne in adult womenacne vulgarisadjunctive treatmentdermocosmeticsmonotherapy

Identifiers

PMID32426933
PMCPMC7496538
OpenAlexW3027055441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.